Pre-Clinical (Discovery and Development)

In preparation for the 8th Annual Improving Solubility Summit, taking place in June, we would like to invite you to take part in a short survey. The survey consists of no more than 8 questions and will take less than 3 minutes to complete. Full Article »

Tenna Juul Schroder, Head of Department, Molecular Pharmacology, Lundbeck, shares her insights on compound management in an ever-changing organisation and discusses new compound management strategies involving outsourcing to CROs, to be able to support projects with a more flexible solution for hit finding. Full Video »

In a session that will be discussed at the Next Generation Sequencing Asia Conference. Dr. Axel Hillmer, Senior Research Scientist, for the Genome Institute of Singapore, outlines some of the challenges to understand the genomic structural variations in cancer to Bryan Camoens. Full Podcast »

PM is no longer about the pharma industry alone – the players/stakeholders go far beyond the pharmaceutical and biotechnology industries, presenting a new challenge in assembling diverse technologies and partners working together. Success in this space will require new approaches, new relationships, and new ways of thinking. Full Column »

The zebrafish is emerging as a complement to existing in vitro technologies and established preclinical in vivo models that can be scaled for high throughput. Technological innovation has helped the zebrafish embryo gain ground as a disease model and an assay system for drug screening. Full Whitepaper »